Drug Profile


Alternative Names: Diotul; F 3616; F 3616M; Flavalfate

Latest Information Update: 10 May 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator FAES Farma
  • Class Antiulcers; Cytoprotectives; Flavones
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed NSAID-induced ulcer
  • Discontinued Duodenal ulcer; Gastric ulcer; Stress ulcer

Most Recent Events

  • 02 Aug 2000 A clinical study has been added to the Peptic Ulcers pharmacodynamics section
  • 02 Aug 2000 A study has been added to the pharmacokinetics and adverse events sections
  • 02 Aug 2000 Four studies have been added to the Peptic Ulcers therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top